Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Sell
24,316
-4,762
-16% -$125K 0.09% 158
2026
Q1
$817K Sell
29,078
-30,539
-51% -$813K 0.14% 122
2025
Q4
$1.48M Buy
59,617
+4,606
+8% +$116K 0.26% 81
2025
Q3
$1.4M Sell
55,011
-12,492
-19% -$308K 0.25% 90
2025
Q2
$1.73M Sell
67,503
-15,443
-19% -$360K 0.33% 66
2025
Q1
$2.1M Buy
82,946
+11,554
+16% +$302K 0.46% 54
2024
Q4
$1.89M Sell
71,392
-28,019
-28% -$760K 0.44% 62
2024
Q3
$2.88M Hold
99,411
0.69% 47
2024
Q2
$2.78M Buy
+99,411
New +$2.74M 0.74% 48

Other funds holding PFE

Drucker Wealth 3.0's PFE Position: Q2 2026 in Review

Drucker Wealth 3.0 reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $125K and leaving 24,316 shares worth $586K. The position accounts for 0.09% of the portfolio, ranked #158.

Drucker Wealth 3.0 first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.88M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Drucker Wealth 3.0 held 24,316 shares of Pfizer worth $586K as of Q2 2026.
  • Drucker Wealth 3.0 sold 4,762 Pfizer shares in Q2 2026, an estimated $125K.
  • Pfizer made up 0.09% of Drucker Wealth 3.0's portfolio in Q2 2026, its #158 holding.
  • Drucker Wealth 3.0 first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Drucker Wealth 3.0's Pfizer position peaked at $2.88M in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Drucker Wealth 3.0's 13F filing for Q2 2026, filed 13 Jul 2026.